About the Authors
- Marike Marjolijn van Beuge
-
* E-mail: m.m.van.beuge@rug.nl
Current address: Department of Pathology and Medical Biology, Division of Medical Biology, University Medical Center Groningen, Groningen, The Netherlands
Affiliation Department of Pharmacokinetics, Toxicology and Targeting, University of Groningen, Groningen, The Netherlands
- Jai Prakash
-
Current address: Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands
Affiliation Department of Pharmacokinetics, Toxicology and Targeting, University of Groningen, Groningen, The Netherlands
- Marie Lacombe
-
Affiliation Kreatech Diagnostics, Amsterdam, The Netherlands
- Eduard Post
-
Affiliation Department of Pharmacokinetics, Toxicology and Targeting, University of Groningen, Groningen, The Netherlands
- Catharina Reker-Smit
-
Affiliation Department of Pharmacokinetics, Toxicology and Targeting, University of Groningen, Groningen, The Netherlands
- Leonie Beljaars
-
Affiliation Department of Pharmacokinetics, Toxicology and Targeting, University of Groningen, Groningen, The Netherlands
- Klaas Poelstra
-
Affiliation Department of Pharmacokinetics, Toxicology and Targeting, University of Groningen, Groningen, The Netherlands
Competing Interests
KP is scientific advisor and shareholder (<5%) of BiOrion Technologies B.V., a company dedicated to the commercialization of drug carriers, including the carrier presented here. ML is an employee of Kreatech Diagnostics. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: MMVB JP LB KP. Performed the experiments: MMVB ML EP CRS. Analyzed the data: MMVB JP LB KP. Contributed reagents/materials/analysis tools: JP ML. Wrote the paper: MMVB JP KP.